Home  >> Transactions>> Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience, Inc. (Nasdaq: HBIO), Holliston, MA, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired AHN Biotechnologie GmbH (“AHN”). Based in Nordhausen, Germany, AHN is a manufacturer of plastic consumable laboratory products including pipette tips.  This acquisition is complementary to Harvard’s Biochrom product line of molecular biology instruments. EC Mergers & Acquisitions acted as exclusive financial advisor to Harvard Bioscience on this transaction.

Others

Xylem has sold Sensus Precision Die Casting (Yangzhou) to SORL Auto Parts      Learn More >>
Randstad has sold Locum Medical Group to Health Carousel      Learn More >>
EMX Industries has been sold to Watervale      Learn More >>
Steel Partners has acquired PST Group      Learn More >>
Galileo TP has been sold to Burke Porter Group      Learn More >>
Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>
Ldetek has been sold to Battery Ventures’ Process Sensing Technologies Group      Learn More >>
Axel Johnson International acquires MAK Aandrijvingen      Learn More >>
SPX has acquired CUES, Inc.      Learn More >>
Dickson Data has been sold to May River Capital      Learn More >>